[
  {
    "ts": null,
    "headline": "Abbott Laboratories stock outperforms competitors on strong trading day",
    "summary": "Abbott Laboratories stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=ca09780abd1e45278a6d0c08be0657b62aef8f71a61dd3f4962bc1eced55c539",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731947760,
      "headline": "Abbott Laboratories stock outperforms competitors on strong trading day",
      "id": 131474063,
      "image": "",
      "related": "ABT",
      "source": "MarketWatch",
      "summary": "Abbott Laboratories stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=ca09780abd1e45278a6d0c08be0657b62aef8f71a61dd3f4962bc1eced55c539"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Laboratories : Late Breaking Data Reinforce Long Term Benefits of Abbott's Amplatzer™ Amulet™ Device for People With Atrial Fibrillation at Risk of Stroke",
    "summary": "New five-year outcomes presented at American Heart Association's Scientific Sessions show that Amplatzer Amulet helps more patients avoid long-term use of blood-thinning medication compared to...",
    "url": "https://finnhub.io/api/news?id=2c1665837283c6c88fc8a04410361a54972b684727173a7cfdec438621c7f102",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731942065,
      "headline": "Abbott Laboratories : Late Breaking Data Reinforce Long Term Benefits of Abbott's Amplatzer™ Amulet™ Device for People With Atrial Fibrillation at Risk of Stroke",
      "id": 131459198,
      "image": "",
      "related": "ABT",
      "source": "Finnhub",
      "summary": "New five-year outcomes presented at American Heart Association's Scientific Sessions show that Amplatzer Amulet helps more patients avoid long-term use of blood-thinning medication compared to...",
      "url": "https://finnhub.io/api/news?id=2c1665837283c6c88fc8a04410361a54972b684727173a7cfdec438621c7f102"
    }
  },
  {
    "ts": null,
    "headline": "Inside a $400 billion bet on the brain-computer interface revolution",
    "summary": "Morgan Stanley's latest report pegs the BCI market at $400 billion — signaling to investors that this revolutionary technology is the next big bet in medtech.",
    "url": "https://finnhub.io/api/news?id=b2eeb6c580caed413dd9245d103d702af5f83d4b81f2e6c91fdc1daded39c605",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731942057,
      "headline": "Inside a $400 billion bet on the brain-computer interface revolution",
      "id": 131442302,
      "image": "https://s.yimg.com/ny/api/res/1.2/Yqd1i77PdiEc3c9Av.HxWw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MzQ-/https://s.yimg.com/os/creatr-uploaded-images/2024-10/f3dfdd60-a29b-11ef-bbbf-e50392a5da6b",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Morgan Stanley's latest report pegs the BCI market at $400 billion — signaling to investors that this revolutionary technology is the next big bet in medtech.",
      "url": "https://finnhub.io/api/news?id=b2eeb6c580caed413dd9245d103d702af5f83d4b81f2e6c91fdc1daded39c605"
    }
  }
]